{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:34:45Z","timestamp":1782390885391,"version":"3.54.5"},"reference-count":8,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      A 22-year-old male with a known history of drug abuse presented to our department with prolonged agitated delirium, myocloni, tachycardia and subfebrile temperature after the deliberate ingestion of opium poppy tea (\n                      <jats:italic toggle=\"yes\">Papaver somniferum<\/jats:italic>\n                      L.) together with the methaqualone analog SL-164 (5-chloro-3-(4-chloro-2-methylphenyl)-2-methyl-4(\n                      <jats:italic toggle=\"yes\">3H<\/jats:italic>\n                      )-quinazolinone) which is sold online as a designer drug.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SL-164 and its hydroxy metabolites were detected in serum and urine via liquid chromatography-quadrupole-time-of-flight mass spectrometry (LC-QTOF-MS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pronounced delirium was treated with benzodiazepines and neuroleptics; temporary medical restraint had to be applied. Symptoms completely resolved over the next 72\u2009h and the patient was discharged on day three able to give consent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although methaqualone was a popular and widespread sedative in the 1950s and 60\u2009s before its discontinuation in the USA in 1985, derivatives of the methaqualone class have not previously played a large role as drugs of abuse in the rapidly growing market of new psychoactive substances. To our knowledge, this is the first case of agitated delirium with detection of SL-164 and hydroxylated metabolites in a patient's serum and urine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2021.1903648","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T15:18:34Z","timestamp":1616599114000},"page":"503-505","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Return of the Quaaludes? Prolonged agitated delirium after intentional ingestion of the methaqualone analog SL-164 \u2013 a case report"],"prefix":"10.1177","volume":"42","author":[{"given":"Katrin","family":"Romanek","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Division of Clinical Toxicology and Poison Control Centre Munich, TUM School of Medicine, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-0417","authenticated-orcid":false,"given":"Helena","family":"Fels","sequence":"additional","affiliation":[{"name":"Forensic Toxicological Centre (FTC) Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Dame","sequence":"additional","affiliation":[{"name":"Forensic Toxicological Centre (FTC) Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Skopp","sequence":"additional","affiliation":[{"name":"Forensic Toxicological Centre (FTC) Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9613-0525","authenticated-orcid":false,"given":"Frank","family":"Musshoff","sequence":"additional","affiliation":[{"name":"Forensic Toxicological Centre (FTC) Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Eiglmeier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Division of Clinical Toxicology and Poison Control Centre Munich, TUM School of Medicine, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4753-2747","authenticated-orcid":false,"given":"Florian","family":"Eyer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Division of Clinical Toxicology and Poison Control Centre Munich, TUM School of Medicine, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.099291"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198804000-00001"},{"key":"e_1_3_5_4_2","first-page":"1945","article-title":"Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164)","volume":"19","author":"Saito C","year":"1969","unstructured":"Saito C, , Sakai S, , Yukawa Y, . Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164). Arzneimittelforschung. 1969;19:1945\u20131949.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_5_5_2","unstructured":"Yamamoto H Inaba S Arasaki S . Compositions and methods for tranquilizing with substituted 3-phenyl-4-quinazolinone derivatives. Patent No. US3651230A. Sumitomo Chemical Co. Ltd. Osaka Japan 1972."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2012.758855"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973143314"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001010050223"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.65.2.204"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1903648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1903648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1903648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:31:41Z","timestamp":1780507901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1903648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1080\/08897077.2021.1903648"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1903648","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}